TLR9 expressed on plasma membrane acts as a negative regulator of human B cell response

Journal of Autoimmunity

Volumn 51, Issue , 2014, Pages 23-29

  Guerrier, Thomas ^a   Pochard, Pierre ^a   Lahiri, Ayan ^a   Youinou, Pierre ^a,b   Pers, Jacques Olivier ^a,b   Jamin, Christophe ^a,b  

^a UNIVERSITÉ EUROPÉENNE DE BRETAGNE   (France)

^b BREST UNIVERSITY HOSPITAL   (France)

Author keywords

B lymphocytes; Cell surface; CpG B; Negative regulator; Stimulation; TLR9

Indexed keywords

ANTIBODY; METHYL CPG BINDING PROTEIN; OLIGODEOXYNUCLEOTIDE; TOLL LIKE RECEPTOR 9; TYROSINE; CPG-OLIGONUCLEOTIDE; LIGAND; OLIGODEOXYRIBONUCLEOTIDE; PROTEIN BINDING;

ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CD25+ T LYMPHOCYTE; CELL MEMBRANE; CELL SURFACE; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; LIPID RAFT; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; UPREGULATION; CELL CULTURE; IMMUNOLOGY; IMMUNOMODULATION; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; METABOLISM;

B-LYMPHOCYTES; CELL MEMBRANE; CELLS, CULTURED; HUMANS; IMMUNOMODULATION; IMMUNOPHENOTYPING; LIGANDS; LYMPHOCYTE ACTIVATION; OLIGODEOXYRIBONUCLEOTIDES; PROTEIN BINDING; TOLL-LIKE RECEPTOR 9;

EID: 84901282752     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2014.02.005     Document Type: Article

References (39)

1. Abdelsadik A., Trad A. Toll-like receptors on the fork roads between innate and adaptive immunity. Hum Immunol 2011, 72:1188-1193.
2. Kawai T., Akira S. TLR signaling. Semin Immunol 2007, 19:24-32.
3. Guerrier T., Le Pottier L., Devauchelle V., Pers J.O., Jamin C., Youinou P. Role of Toll-like receptors in primary Sjogren's syndrome with a special emphasis on B-cell maturation within exocrine tissues. JAutoimmun 2012, 39:69-76.
4. Rawlings D.J., Schwartz M.A., Jackson S.W., Meyer-Bahlburg A. Integration of B cell responses through Toll-like receptors and antigen receptors. Nat Rev Immunol 2012, 12:282-294.
5. Meyer-Bahlburg A., Rawlings D.J. Differential impact of Toll-like receptor signaling on distinct B cell subpopulations. Front Biosci (Landmark Ed) 2012, 17:1499-1516.
6. Papadimitraki E.D., Bertsias G.K., Boumpas D.T. Toll like receptors and autoimmunity: a critical appraisal. JAutoimmun 2007, 29:310-318.
7. Barbalat R., Ewald S.E., Mouchess M.L., Barton G.M. Nucleic acid recognition by the innate immune system. Annu Rev Immunol 2011, 29:185-214.
8. Rutz M., Metzger J., Gellert T., Luppa P., Lipford G.B., Wagner H., et al. Toll-like receptor 9 binds single-stranded CpG-DNA in a sequence- and pH-dependent manner. Eur J Immunol 2004, 34:2541-2550.
9. Park B., Brinkmann M.M., Spooner E., Lee C.C., Kim Y.M., Ploegh H.L. Proteolytic cleavage in an endolysosomal compartment is required for activation of Toll-like receptor 9. Nat Immunol 2008, 9:1407-1414.
10. Ewald S.E., Lee B.L., Lau L., Wickliffe K.E., Shi G.P., Chapman H.A., et al. The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor. Nature 2008, 456:658-662.
11. Barton G.M., Kagan J.C., Medzhitov R. Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA. Nat Immunol 2006, 7:49-56.
12. Mouchess M.L., Arpaia N., Souza G., Barbalat R., Ewald S.E., Lau L., et al. Transmembrane mutations in Toll-like receptor 9 bypass the requirement for ectodomain proteolysis and induce fatal inflammation. Immunity 2011, 35:721-732.
13. Lee J., Mo J.H., Katakura K., Alkalay I., Rucker A.N., Liu Y.T., et al. Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells. Nat Cell Biol 2006, 8:1327-1336.
14. Schmausser B., Andrulis M., Endrich S., Lee S.K., Josenhans C., Muller-Hermelink H.K., et al. Expression and subcellular distribution of toll-like receptors TLR4, TLR5 and TLR9 on the gastric epithelium in Helicobacter pylori infection. Clin Exp Immunol 2004, 136:521-526.
15. Eaton-Bassiri A., Dillon S.B., Cunningham M., Rycyzyn M.A., Mills J., Sarisky R.T., et al. Toll-like receptor 9 can be expressed at the cell surface of distinct populations of tonsils and human peripheral blood mononuclear cells. Infect Immun 2004, 72:7202-7211.
16. Dasari P., Nicholson I.C., Hodge G., Dandie G.W., Zola H. Expression of toll-like receptors on B lymphocytes. Cell Immunol 2005, 236:140-145.
17. Baiyee E.E., Flohe S., Lendemans S., Bauer S., Mueller N., Kreuzfelder E., et al. Expression and function of Toll-like receptor 9 in severely injured patients prone to sepsis. Clin Exp Immunol 2006, 145:456-462.
18. Chaturvedi A., Dorward D., Pierce S.K. The B cell receptor governs the subcellular location of Toll-like receptor 9 leading to hyperresponses to DNA-containing antigens. Immunity 2008, 28:799-809.
19. Kubarenko A.V., Ranjan S., Rautanen A., Mills T.C., Wong S., Vannberg F., et al. Anaturally occurring variant in human TLR9, P99L, is associated with loss of CpG oligonucleotide responsiveness. JBiol Chem 2010, 285:36486-36494.
20. Knezevic J., Pavlinic D., Rose W.A., Leifer C.A., Bendelja K., Gabrilovac J., et al. Heterozygous carriage of a dysfunctional Toll-like receptor 9 allele affects CpG oligonucleotide responses in B cells. JBiol Chem 2012, 287:24544-24553.
21. Busconi L., Bauer J.W., Tumang J.R., Laws A., Perkins-Mesires K., Tabor A.S., et al. Functional outcome of B cell activation by chromatin immune complex engagement of the B cell receptor and TLR9. JImmunol 2007, 179:7397-7405.
22. Lee J., Gonzales-Navajas J.M., Raz E. The "polarizing-tolerizing" mechanism of intestinal epithelium: its relevance to colonic homeostasis. Semin Immunopathol 2008, 30:3-9.
23. Kagan J.C., Su T., Horng T., Chow A., Akira S., Medzhitov R. TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta. Nat Immunol 2008, 9:361-368.
24. Kato M., McDonald K.J., Khan S., Ross I.L., Vuckovic S., Chen K., et al. Expression of human DEC-205 (CD205) multilectin receptor on leukocytes. Int Immunol 2006, 18:857-869.
25. Lahoud M.H., Ahmet F., Zhang J.G., Meuter S., Policheni A.N., Kitsoulis S., et al. DEC-205 is a cell surface receptor for CpG oligonucleotides. Proc Natl Acad Sci U S A 2012, 109:16270-16275.
26. Abdulkhalek S., Szewczuk M.R. Neu1 sialidase and matrix metalloproteinase-9 cross-talk regulates nucleic acid-induced endosomal TOLL-like receptor-7 and -9 activation, cellular signaling and pro-inflammatory responses. Cell Signal 2013, 25:2093-2105.
27. Latz E., Verma A., Visintin A., Gong M., Sirois C.M., Klein D.C., et al. Ligand-induced conformational changes allosterically activate Toll-like receptor 9. Nat Immunol 2007, 8:772-779.
28. Amith S.R., Jayanth P., Franchuk S., Siddiqui S., Seyrantepe V., Gee K., et al. Dependence of pathogen molecule-induced toll-like receptor activation and cell function on Neu1 sialidase. Glycoconj J 2009, 26:1197-1212.
29. Finlay T.M., Abdulkhalek S., Gilmour A., Guzzo C., Jayanth P., Amith S.R., et al. Thymoquinone-induced Neu4 sialidase activates NFkappaB in macrophage cells and pro-inflammatory cytokines invivo. Glycoconj J 2010, 27:583-600.
30. Abdulkhalek S., Guo M., Amith S.R., Jayanth P., Szewczuk M.R. G-protein coupled receptor agonists mediate Neu1 sialidase and matrix metalloproteinase-9 cross-talk to induce transactivation of Toll-like receptors and cellular signaling. Cell Signal 2012, 24:2035-2042.
31. Baumann C.L., Aspalter I.M., Sharif O., Pichlmair A., Bluml S., Grebien F., et al. CD14 is a coreceptor of Toll-like receptors 7 and 9. JExp Med 2010, 207:2689-2701.
32. Fitzgerald K.A., Rowe D.C., Golenbock D.T. Endotoxin recognition and signal transduction by the TLR4/MD2-complex. Microbes Infect 2004, 6:1361-1367.
33. Schmitz G., Orso E. CD14 signalling in lipid rafts: new ligands and co-receptors. Curr Opin Lipidol 2002, 13:513-521.
34. Tian J., Avalos A.M., Mao S.Y., Chen B., Senthil K., Wu H., et al. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol 2007, 8:487-496.
35. Avalos A.M., Kiefer K., Tian J., Christensen S., Shlomchik M., Coyle A.J., et al. RAGE-independent autoreactive B cell activation in response to chromatin and HMGB1/DNA immune complexes. Autoimmunity 2010, 43:103-110.
36. Li G., Liang X., Lotze M.T. HMGB1: the central cytokine for all lymphoid cells. Front Immunol 2013, 4:68.
37. Lanzavecchia A., Sallusto F. Toll-like receptors and innate immunity in B-cell activation and antibody responses. Curr Opin Immunol 2007, 19:268-274.
38. Marshak-Rothstein A. Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol 2006, 6:823-835.
39. Nickerson K.M., Christensen S.R., Cullen J.L., Meng W., Luning Prak E.T., Shlomchik M.J. TLR9 promotes tolerance by restricting survival of anergic anti-DNA B cells, yet is also required for their activation. JImmunol 2013, 190:1447-1456.